Verve Therapeutics
VERV
#6795
Rank
A$0.77 B
Marketcap
$9.18
Share price
11.24%
Change (1 day)
-56.30%
Change (1 year)

Earnings for Verve Therapeutics (VERV)

Earnings in 2024 (TTM): -A$0.34 Billion

According to Verve Therapeutics's latest financial reports the company's current earnings are A$24.39 Million. In 2023 the company made an earning of -A$0.36 Billion a decrease over its 2022 earnings that were of -A$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verve Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.34 Billion-5.7%
2023 -A$0.36 Billion34.67%
2022 -A$0.27 Billion90.3%
2021 -A$0.14 Billion114.31%
2020 -A$65 Million